FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149060580> ?p ?o ?g. }

• W2149060580 endingPage "1172" @default.
• W2149060580 startingPage "1162" @default.
• W2149060580 abstract "Recent experiments have shown that the congener Abeta(1-40)[D23-K28], in which the side chains of charged residues Asp23 and Lys28 are linked by a lactam bridge, forms amyloid fibrils that are structurally similar to the wild type (WT) Abeta peptide, but at a rate that is nearly 1000 times faster. We used all atom molecular dynamics simulations in explicit water, and two force fields, of the WT dimer, a monomer with the lactam bridge (Abeta(10-35)-lactam[D23-K28]), and the monomer and dimers with harmonically constrained D23-K28 salt bridge (Abeta(10-35)[D23-K28]) to understand the origin of the enhanced fibril rate formation. The simulations show that the assembly competent fibril-like monomer (N*) structure, which is present among the conformations sampled by the isolated monomer, with strand conformations in the residues spanning the N and C termini and a bend involving residues D(23) VGSNKG(29), are populated to a much greater extent in Abeta(10-35)[D23-K28] and Abeta(10-35)-lactam[D23-K28] than in the WT, which has negligible probability of forming N*. The salt bridge in N* of Abeta(10-35)[D23-K28], whose topology is similar to that found in the fibril, is hydrated. The reduction in the free energy barrier to fibril formation in Abeta(10-35)[D23-K28] and in Abeta(10-35)-lactam[D23-K28], compared to the WT, arises largely due to entropic restriction which enables the bend formation. A decrease in the entropy of the unfolded state and the lesser penalty for conformational rearrangement including the formation of the salt bridge in Abeta peptides with D23-K28 constraint results in a reduction in the kinetic barrier in the Abeta(1-40)-lactam[D23-K28] congener compared to the WT. The decrease in the barrier, which is related to the free energy cost of forming a bend, is estimated to be in the range (4-7)k(B)T. Although a number of factors determine the growth of fibrils, the decrease in the free energy barrier, relative to the WT, to N* formation is a major factor in the rate enhancement in the fibril formation of Abeta(1-40)[D23-K28] congener. Qualitatively similar results were obtained using simulations of Abeta(9-40) peptides and various constructs related to the Abeta(10-35) systems that were probed using OPLS and CHARMM force fields. We hypothesize that mutations or other constraints that preferentially enhance the population of the N* species would speed up aggregation rates. Conversely, ligands that lock it in the fibril-like N* structure would prevent amyloid formation." @default.
• W2149060580 created "2016-06-24" @default.
• W2149060580 creator A5036725653 @default.
• W2149060580 creator A5058069370 @default.
• W2149060580 creator A5075084768 @default.
• W2149060580 date "2009-01-06" @default.
• W2149060580 modified "2023-10-14" @default.
• W2149060580 title "Influence of Preformed Asp23−Lys28 Salt Bridge on the Conformational Fluctuations of Monomers and Dimers of Aβ Peptides with Implications for Rates of Fibril Formation" @default.
• W2149060580 cites W1552345552 @default.
• W2149060580 cites W1964991231 @default.
• W2149060580 cites W1965181102 @default.
• W2149060580 cites W1965895512 @default.
• W2149060580 cites W1972758026 @default.
• W2149060580 cites W1980146626 @default.
• W2149060580 cites W1981735680 @default.
• W2149060580 cites W1984964811 @default.
• W2149060580 cites W1994081387 @default.
• W2149060580 cites W2000659036 @default.
• W2149060580 cites W2001773296 @default.
• W2149060580 cites W2008151389 @default.
• W2149060580 cites W2010160084 @default.
• W2149060580 cites W2011056613 @default.
• W2149060580 cites W2014451295 @default.
• W2149060580 cites W2015521587 @default.
• W2149060580 cites W2024473468 @default.
• W2149060580 cites W2024748787 @default.
• W2149060580 cites W2027408247 @default.
• W2149060580 cites W2029667189 @default.
• W2149060580 cites W2032920422 @default.
• W2149060580 cites W2038758364 @default.
• W2149060580 cites W2040721710 @default.
• W2149060580 cites W2046847750 @default.
• W2149060580 cites W2048866816 @default.
• W2149060580 cites W2054881399 @default.
• W2149060580 cites W2067214887 @default.
• W2149060580 cites W2093194974 @default.
• W2149060580 cites W2093942461 @default.
• W2149060580 cites W2096125044 @default.
• W2149060580 cites W2096410114 @default.
• W2149060580 cites W2099092270 @default.
• W2149060580 cites W2110613705 @default.
• W2149060580 cites W2117537971 @default.
• W2149060580 cites W2118280241 @default.
• W2149060580 cites W2122294662 @default.
• W2149060580 cites W2137261793 @default.
• W2149060580 cites W2139772066 @default.
• W2149060580 cites W2141920771 @default.
• W2149060580 cites W2147466870 @default.
• W2149060580 cites W2150981663 @default.
• W2149060580 cites W2152184357 @default.
• W2149060580 cites W2155073864 @default.
• W2149060580 cites W2162319691 @default.
• W2149060580 cites W2163210644 @default.
• W2149060580 cites W2165021720 @default.
• W2149060580 cites W2166848357 @default.
• W2149060580 cites W2167366010 @default.
• W2149060580 doi "https://doi.org/10.1021/jp808914c" @default.
• W2149060580 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3098509" @default.
• W2149060580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19125574" @default.
• W2149060580 hasPublicationYear "2009" @default.
• W2149060580 type Work @default.
• W2149060580 sameAs 2149060580 @default.
• W2149060580 citedByCount "142" @default.
• W2149060580 countsByYear W21490605802012 @default.
• W2149060580 countsByYear W21490605802013 @default.
• W2149060580 countsByYear W21490605802014 @default.
• W2149060580 countsByYear W21490605802015 @default.
• W2149060580 countsByYear W21490605802016 @default.
• W2149060580 countsByYear W21490605802017 @default.
• W2149060580 countsByYear W21490605802018 @default.
• W2149060580 countsByYear W21490605802019 @default.
• W2149060580 countsByYear W21490605802020 @default.
• W2149060580 countsByYear W21490605802021 @default.
• W2149060580 countsByYear W21490605802022 @default.
• W2149060580 countsByYear W21490605802023 @default.
• W2149060580 crossrefType "journal-article" @default.
• W2149060580 hasAuthorship W2149060580A5036725653 @default.
• W2149060580 hasAuthorship W2149060580A5058069370 @default.
• W2149060580 hasAuthorship W2149060580A5075084768 @default.
• W2149060580 hasBestOaLocation W21490605802 @default.
• W2149060580 hasConcept C104317684 @default.
• W2149060580 hasConcept C12554922 @default.
• W2149060580 hasConcept C143065580 @default.
• W2149060580 hasConcept C147597530 @default.
• W2149060580 hasConcept C166940927 @default.
• W2149060580 hasConcept C178790620 @default.
• W2149060580 hasConcept C185592680 @default.
• W2149060580 hasConcept C27523624 @default.
• W2149060580 hasConcept C2779281246 @default.
• W2149060580 hasConcept C2779546866 @default.
• W2149060580 hasConcept C30765947 @default.
• W2149060580 hasConcept C521977710 @default.
• W2149060580 hasConcept C55493867 @default.
• W2149060580 hasConcept C59593255 @default.
• W2149060580 hasConcept C8010536 @default.
• W2149060580 hasConcept C86803240 @default.
• W2149060580 hasConceptScore W2149060580C104317684 @default.
• W2149060580 hasConceptScore W2149060580C12554922 @default.

• next